Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CATXCATX
8 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in PERSPECTIVE THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1.7M shares of CATX (PERSPECTIVE THERAPEUTICS INC), worth $5.9M as of 2026-Q2. The position was increased (+39.6% shares). CATX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$5.9M

Current Shares

1.7M

Total Value Change

-$80,122

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+39.6%
$5.9M0.0%$3.41
36
2026-Q1
Increased
1.2M
+676.9%
$5.2M0.0%$4.17
44
2025-Q4
Decreased
159,837
-19.2%
$439,5520.0%$2.75
0
2025-Q3
Decreased
197,710
-27.3%
$678,1450.0%$3.43
0
2025-Q2
Decreased
272,098
-10.2%
$936,0170.0%$3.44
0
2025-Q1
Decreased
302,819
-66.5%
$645,0040.0%$2.13
0
2024-Q4
Increased
902,918
+101.2%
$2.9M0.0%$3.19
42
2024-Q3
New
448,683
-
$6M0.0%$13.35
38

Other major holders of CATX: FMR LLC, Janus Henderson Group Ltd., BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used